SeaSpine announced financial results for the first quarter ending March 31, 2016.
Here are nine takeaways:
1. SeaSpine's revenue totaled $31.4 million in the first quarter 2016, a 2.8 percent decline compared to the first quarter of 2015.
2. The company's net loss for the first quarter of 2016 was $12 million, up from a net loss of $9.9 million in the first quarter of 2015.
3. Revenue from orthobiologics products totaled $16.7 million, a 3.9 percent increase from the first quarter of 2015. U.S. orthobiologics product revenue was $14.9 million in this quarter.
4. Revenue from spinal hardware totaled $14.7 million, down 9.5 percent from the same period last year.
5. U.S. spinal hardware product revenue reached $13.6 million, a 9.7 percent decrease compared to the first quarter of 2015.
6. The company attributed the decline in spinal hardware sales to "continued mid-single digit pricing pressure in the U.S. and lower case volume on legacy products."
7. Operating expenses for the first quarter of 2016 totaled $29.4 million, a $1.4 million increase compared to the same period.
8. Additionally, research and development expenses totaled $2.8 million, 8.8 percent of revenue.
9. SeaSpine continues to expect full-year 2016 revenue to be in a range of $136 million to $140 million, reflecting 2 percent to 5 percent growth over full-year 2015 revenue.